ConductScience.org, home

Paper20437116

Oral cancer chemotherapy: the critical interplay between patient education and patient safety.

Halfdanarson TR and 1 other. Curr Oncol Rep, 2010. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Papers, record 20437116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20437116

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
PubMed
Journal
Curr Oncol Rep
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2022-11-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Halfdanarson TRThorvardur R
2Jatoi AAminah

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Administration, Oral
Humans
Patient Compliance
Patient Education as Topic
Self Administration

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K24 CA131099NCI NIH HHSUnited StatesK24CA131099PubMed and NIHNIH RePORTER
R21 CA134432NCI NIH HHSUnited StatesR21CA134432PubMedNIH RePORTER
K24CA131099NCI NIH HHSUnited StatesK24CA131099PubMed and NIHNIH RePORTER

Download CSV of grants

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119692680Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.N Engl J Med2009https://conductscience.org/library/papers/19692680PubMed
215987918Capecitabine as adjuvant treatment for stage III colon cancer.N Engl J Med2005https://conductscience.org/library/papers/15987918PubMed
318063536Oral chemotherapy medications: the need for a nurse's touch.Clin J Oncol Nurs2007https://conductscience.org/library/papers/18063536PubMed
411709569Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.J Clin Oncol2001https://conductscience.org/library/papers/11709569PubMed
516512995A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.Clin Colorectal Cancer2006https://conductscience.org/library/papers/16512995PubMed
68996131Patient preferences for oral versus intravenous palliative chemotherapy.J Clin Oncol1997https://conductscience.org/library/papers/8996131PubMed
719306355First-line therapy for chronic myeloid leukemia: Past, present, and future.Am J Hematol2009https://conductscience.org/library/papers/19306355PubMed
819188677Effects of food on the relative bioavailability of lapatinib in cancer patients.J Clin Oncol2009https://conductscience.org/library/papers/19188677PubMed
919150950Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.Ann Oncol2009https://conductscience.org/library/papers/19150950PubMed
1017223629Oral chemotherapy safety practices at US cancer centres: questionnaire survey.BMJ2007https://conductscience.org/library/papers/17223629PubMed
1117513814Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.J Clin Oncol2007https://conductscience.org/library/papers/17513814PubMed
129563888Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.Clin Cancer Res1998https://conductscience.org/library/papers/9563888PubMed
1318985046Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.Br J Cancer2008https://conductscience.org/library/papers/18985046PubMed
1417925496Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management.Ann Pharmacother2007https://conductscience.org/library/papers/17925496PubMed
158270984Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.J Clin Oncol1994https://conductscience.org/library/papers/8270984PubMed
1616198223Adherence beliefs among breast cancer patients taking tamoxifen.Patient Educ Couns2005https://conductscience.org/library/papers/16198223PubMed
1716155797Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer.Breast Cancer Res Treat2005https://conductscience.org/library/papers/16155797PubMed
1819786650American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards.J Clin Oncol2009https://conductscience.org/library/papers/19786650PubMed
1919816160A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents.Cancer Nurs2009https://conductscience.org/library/papers/19816160PubMed
2018377852NCCN Task Force Report: Oral chemotherapy.J Natl Compr Canc Netw2008https://conductscience.org/library/papers/18377852PubMed

See all 22 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42732435The Effect of Two Different Pharmacist-led Educations Provided to Patients with Colorectal Cancer Receiving an Oral Antineoplastic Agent: A Comparative Interventional Study.J Res Pharm Pract2026https://conductscience.org/library/papers/42732435PubMed
41707192A Short Patient-Reported Outcome Measure for Oral Anticancer Agents: Multicenter Observational Study.JMIR Form Res2026https://conductscience.org/library/papers/41707192PubMed
41425733Unmet information needs and knowledge gaps in cancer patients undergoing oral anticancer therapy.Explor Res Clin Soc Pharm2025https://conductscience.org/library/papers/41425733PubMed
41325647The impact of vertical integration on health care delivery and costs: Evidence from physician-pharmacy integration.J Health Econ2025https://conductscience.org/library/papers/41325647PubMed
41185868Recent advancement in polymeric nanoparticles for oral chemotherapy: Transforming cancer treatment.Bioimpacts2025https://conductscience.org/library/papers/41185868PubMed
40626013Wernicke's encephalopathy following radical gastrectomy and prolonged parenteral nutrition: a case report of pyloric obstruction and undisclosed psychiatric comorbidity.Front Oncol2025https://conductscience.org/library/papers/40626013PubMed
40525538Perceptions of oncology healthcare professional providing care to older adults prescribed oral anticancer medications in the United States: A qualitative study.J Oncol Pharm Pract2025https://conductscience.org/library/papers/40525538PubMed
40130809Trends in the Dispensing of Oral Anti-Cancer Medications Across Australia Over 10 Years.Pharmacoepidemiol Drug Saf2025https://conductscience.org/library/papers/40130809PubMed
39091323Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.Ther Adv Hematol2024https://conductscience.org/library/papers/39091323PubMed
37081567Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol.Syst Rev2023https://conductscience.org/library/papers/37081567PubMed
36612264Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36612264PubMed
34677244Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective.Curr Oncol2021https://conductscience.org/library/papers/34677244PubMed
33768501Patients' Perceived Continuity of Care and Adherence to Oral Anticancer Therapy: a Prospective Cohort Mediation Study.J Gen Intern Med2021https://conductscience.org/library/papers/33768501PubMed
33409726Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study).Support Care Cancer2021https://conductscience.org/library/papers/33409726PubMed
32588349
Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care.
J Cancer Educ2022https://conductscience.org/library/papers/32588349PubMed
31848704From theory to practice: implementing a standardized, interactive education session on oral anticancer medication (OAM) for patients and their caregivers.Support Care Cancer2020https://conductscience.org/library/papers/31848704PubMed
31758323Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program.Support Care Cancer2020https://conductscience.org/library/papers/31758323PubMed
31164024Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs.Leuk Lymphoma2019https://conductscience.org/library/papers/31164024PubMed
30625194Comparison between continuous and discrete doses for model based designs in cancer dose finding.PLoS One2019https://conductscience.org/library/papers/30625194PubMed
30463094Self-Care Support for Patients with Gastrointestinal Cancer: iCancerHealth.Appl Clin Inform2018https://conductscience.org/library/papers/30463094PubMed

See all 31 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20437116

GET https://conductscience.org/api/papers/v1/20437116/references?page=2